EQ Appoints Nicholas Nichols as Executive Vice President of Mutual Funds GlobeNewswire November 07, 2025 NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) — Equiniti (EQ), a leading provider of transfer agent and share ownership services, has named Nicholas (Nick) Nichols as Executive Vice President of the Mutual Funds team. In this role, Nichols will help […]
Pharmaceutical Tube Packaging Market Size, Trends, Regional Share (NA/EU/APAC/LA/MEA) and Competitive Analysis According to Towards Packaging consultants, the global pharmaceutical tube packaging market is expected to experience steady growth throughout the forecast period, expanding significantly by 2034 from its valuation in 2025. The market is anticipated to register a strong compound annual growth rate, driven
BioAtla's Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas GlobeNewswire November 07, 2025 — Mec-V demonstrates median OS of 21.5 months in patients with treatment-refractory leiomyosarcoma, liposarcoma, and undifferentiated pleomorphic sarcoma compared with approximately 12 months with approved agents — Mec-V
T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Meeting GlobeNewswire November 07, 2025 — Comprehensive TK-6302 data demonstrate preclinical efficacy and safety, supporting clinical readiness, alongside established scalable manufacturing –TK-6302 Clinical Trial Application planned in Q4 2025 for
Tizona Therapeutics Presents Clinical Translational Evidence of Dual Innate and Adaptive Immune Activation with TTX-080, a First-in-Class HLA-G Antagonist, in Patients with Advanced Solid Tumors at SITC 2025 Enrolling patients in ongoing randomized Phase 1b trial in MSS metastatic colorectal cancer, evaluating TTX-080 in combination with cetuximab + FOLFIRI GlobeNewswire November 07, 2025 SOUTH SAN
Changes in Nokia Corporation's own shares GlobeNewswire November 07, 2025 Nokia CorporationStock Exchange Release7 November 2025 at 16:00 EET Changes in Nokia Corporation's own shares Espoo, Finland – A total of 126 758 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia's equity-based incentive plans in accordance with
Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling Study for Cancer Interception in Lynch Syndrome Carriers GlobeNewswire November 07, 2025 Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling Study for Cancer Interception in Lynch Syndrome Carriers New
Dental Tourism Market to Sustain USD 62.65 Billion at 22.04% CAGR by 2034, Fueled by Rising Demand for Affordable Dental Care Abroad The global dental tourism market size is calculated at USD 10.43 billion in 2025 and is expected to reach around USD 62.65 billion by 2034, growing at a CAGR of 22.04% for the
Precision Optics Announces Product Development Agreement to Deliver Next-Generation Augmented Reality Sub-Systems for Fighter Pilots GlobeNewswire November 07, 2025 GARDNER, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced the receipt of a product
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program GlobeNewswire November 07, 2025 CALABASAS, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing novel brain-penetrant therapeutics for patients